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Abstract- Clinical assessment of distal symmetric polyneuropathy (DPN) involves the evaluation of 
symptoms and signs. Although there are numerous tools to evaluate DPN, there is still a need to determine 
the most sensitive, specific, and accurate tests to detect DPN in a busy outpatient clinical setting. A total of 
107 patients with type 2 diabetes were examined using Michigan Neuropathy Screening Instrument (MNSI). 
Total score of the instrument was used as a standard to calculate sensitivity, specificity and diagnostic 
accuracy of every single item of MNSI to find the most accurate and applicable test for evaluation of DPN. In 
patients’ history, the most sensitive (99.4%) and accurate (78%) symptoms were muscle cramp and weakness. 
Numbness and prickling had lower sensitivity (72.6% and 67.9%, respectively) but greater specificity (65.2% 
and 47.8%). In physical assessment, the most accurate signs were appearance of feet (81.3%), ankle reflexes 
(67.2%), and vibration perception (63.5%). Monofilament test had a sensitivity of 16.7%, accuracy of 31.7% 
with specificity of 87%. Findings show that symptoms such as a muscle cramp, weakness, numbness, and 
prickling, as well as signs such as ankle reflexes, appearance of feet, and vibration could be used as the most 
accurate tests for rapid diagnosis of DPN. In addition, the results suggest that monofilament examination may 
not be the optimum test to detect high risk patients. 
© 2014 Tehran University of Medical Sciences. All rights reserved.  
Acta Medica Iranica, 2014;52(7):519-527.  
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Introduction 
 
Diabetic neuropathy is the most common long-term 
complication of diabetes (1). It has a heterogeneous 
pattern with diverse clinical manifestations. The most 
common form of neuropathy is chronic sensorimotor 
distal symmetric polyneuropathy (DPN) (2) which is 
ultimately characterized by a progressive loss of nerve 
fibers (3), leading to the presence of symptoms and/or 
signs of peripheral nerve dysfunction (4) and altered 
nerve conduction velocity (3). Determination of nerve 
conduction velocity is considered as an effective 
method for identifying DPN (5). This method is 
relatively simple; it is age, and temperature dependent 
(6) and the results vary according to the length and 
proximity of the limb (7).  
In addition, determination of nerve conduction 
velocity is time-consuming and expensive in an 
outpatient setting; especially in developing countries 
without optimal podiatry service that health care 
professionals should provide standards of care in busy 
diabetes clinics (8,9). 
The Michigan Neuropathy Screening Instrument 
(MNSI), Toronto Clinical Neuropathy Score (TCNS), 
Diabetic Neuropathy Symptom Score (DNS), modified 
Neuropathy Symptom Score (NSS), Diabetic 
Neuropathy Examination (DNE), and modified 
Neuropathy Disability Score (NDS) are available as 
alternative methods, in the assessment of DPN; 
however, there is a need to formulate a standard protocol 
for rapid and accurate diagnosis of DPN (10, 11). 
Among the mentioned methods, MNSI is widely 
used for diagnosis of diabetic peripheral neuropathy 
(12). MNSI is a time consuming tool especially in a 
busy clinical setting. Thus, determining the most 
accurate diagnostic test(s) helps the clinicians to assess 
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DPN precisely and rapidly. 
The aim of this study was to determine the 
diagnostic accuracy of every single symptom and sign of 
MNSI, considering the total score as a standard to find 
the most accurate and applicable screening tests to 
detect DPN. 
  
Materials and Methods 
 
One hundred and seven type 2 diabetic subjects were 
enrolled in this study. Those subjects with severe 
peripheral arterial diseases, prior diagnosis of peripheral 
neuropathy, or secondary types of neuropathy were 
excluded. Secondary neuropathy was considered if any 
of the following conditions were present: alcohol 
consumption, renal failure, liver disease, previous cord 
injury, history of lumbar or cervical discopathy, 
inherited forms of neuropathy, occupational neuropathy, 
hypothyroidism, collagen vascular diseases, 
paraneoplastic disorders and immune-mediated 
disorders, and vasculitis.  
MNSI was used for evaluation of DPN in these 
subjects. It comprised two parts, i.e.; “history” and 
“physical assessment”(13). 
The history is a simple tool to assess subjective 
symptoms. The participants were asked to answer 15 
questions. Responses were added to obtain the total 
score. A “yes” response to the items 1-3, 5-6, 8-9, 11-12, 
14-15 was counted as one point for each item and a “no” 
response on items 7, and 13 counted as 1 point. Item 
number 4 which measures impaired circulation and item 
number 10 which measures general asthenia were not 
included in scoring.  
Physical assessment was done by a trained physician 
considering the appearance of feet, ulceration, ankle 
reflexes, vibration perception at great toes, and 
monofilament. Possible obtainable score varied between 0 
and 1 for each item. Appearance of feet was evaluated by 
the presence of deformities, dry skin, callus, infection, 
and fissure. Deformity was diagnosed if any of the 
following conditions was present: flat feet, hammer toes, 
overlapping toes, hallux valgus, joint subluxation, 
prominent metatarsal heads, medial convexity (Charcot 
foot), and amputation. All assessments were done in a 
room with the temperature around 30◦C.  
Test of vibration was performed bilaterally using a 
128 Hz tuning fork placed over the dorsum of the great 
toe on distal interphalangeal (DIP) joint. A zero score 
showed that vibration sensation was intact while “0.5” 
represented a reduced sensation, and “1” was considered 
as lack of vibration sensation.   
The ankle reflexes were examined using an 
appropriate reflex hammer. Tendon reflexes were scored 
bilaterally as 0 for normal, 0.5 for abnormal, and 1 for 
absent responses.  
The monofilament was applied based on the 
protocol provided by Michigan Diabetes Research and 
Training Center (13); for this examination, the 
patient’s foot was supported and we allowed the sole of 
the foot to rest on a flat, warm surface and the filament 
had initially been prestressed (4-6 perpendicular 
applications to the dorsum of the examiners’ first 
finger). It was then applied to the dorsum of the great 
toe midway between the nail fold and the DIP joint. 
The toe was not held directly. The filament was 
applied perpendicularly and briefly, (<1 second) with 
even pressure. When the filament bended, the force of 
10 grams had been applied.  
The 10-g monofilament was applied for ten times 
on each foot, and a “yes” response was indicative of 
the filament sensation. Eight correct responses out of 
10 applications were considered as normal; 1–7 correct 
responses as reduced sensation, and no correct answers 
as absent sensation.  
The total score of the instrument was an ordinal 
numeric variable ranging from 0-10. A total score of >2 
was considered as abnormal. Diagnostic accuracy of 
every single test was calculated considering total score as 
the standard for comparison using 2x2 tables (Table 1, 2). 
The basic measures to quantify the diagnostic accuracy of 
the test include sensitivity, specificity, positive predictive 
value (PPV), and negative predictive value (NPV). 
For each item, subjects were divided into four 
groups; true positive (a), false positive (b), false 
negative (c), and true negative (d).  
In each subject, a symptom/sign was considered as 
true positive when it was present in accompany with an 
obtained total score of >2. False positive was considered 
if the symptom/sign was present on history/clinical 
examination, but the obtained total score was ≤2.  When 
neuropathy was present based on the total score, but the 
symptom/sign was absent on history/clinical 
examination, it was considered as false negative. The 
symptoms/signs which were absent in both 
history/clinical examination were defined as true 
negative if the total score of the instrument was ≤2. 
Diagnostic accuracy, PPV, and NPV of each test 
were derived from the same data. 
The ethical approval was obtained from the ethics 
committee of the Tehran University of Medical 
Sciences, and all participants signed a written consent 
form. 
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Results 
 
A total of 107 patients participated in this study. 
Seventy-two (67.3%) were female. The mean age was 
57.6 (10.2 SD), and the mean duration of diabetes was 
10.2 (7.3 SD) years. The prevalence of DPN in the current 
study  was  high  (78.5%).  Table 3 illustrates baseline 
characteristics of the participants. 
In patients' history, the most sensitive symptoms 
were muscle cramp and weakness (99.4%), followed by 
numbness (72.6%) and prickling feeling (67.9%). 
History of amputation (97.9%) and open sore (95.7%) 
had the greatest specificity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To consider the effect of age on subjective parameters, 
the diagnostic accuracy of numbness was compared in 
patients less than 65 years old with those who were older 
(≥65yrs). The comparison showed that in both groups, the 
diagnostic accuracy of numbness was high; i.e. 67.5% in 
the former and 81.4% in the latter group. 
In physical assessment, appearance of feet and ankle 
reflexes had the highest sensitivity: 99.9% and 76.2%, 
respectively. Ulceration (100%), monofilament sensation 
(87%) and vibration perception at great toes (70%) were 
the most specific tests.  
Considering diagnostic accuracy, muscle cramp (78%), 
 
Table 1. Comparison of symptoms with 
the total score as standard 
Symptoms 
Neuropathy based 
on total score 
Present Absent 
Numbness   
     Present 61 (a) 8 (b) 
     Absent 23 (c) 15 (d) 
Prickling    
     Present 57 (a) 12 (b) 
     Absent 27 (c) 11 (d) 
Burning pain   
     Present 45 (a) 6 (b) 
     Absent 39 (c) 17 (d) 
Dry Skin   
     Present 36 (a) 11 (b) 
     Absent 48 (c) 12 (d) 
Hx of Amputation   
     Present 0 (a) 0 (b) 
     Absent 85 (c) 22 (d) 
Open Sore   
     Present 12 (a) 1 (b) 
     Absent 72 (c) 22 (d) 
Sensitive to touch   
     Present 20 (a) 4 (b) 
     Absent 64 (c) 19 (d) 
Muscle cramp   
     Present 84 (a) 23 (b) 
     Absent 0 (c) 0 (d) 
Hurt by touching with 
bed covers  
 
 
 
 
     Present 23 (a) 6 (b) 
     Absent 61 (c) 17 (d) 
Hurt legs by walking   
     Present 17 (a) 4 (b) 
     Absent 67 (c) 19 (d) 
Worse at night   
     Present 39 (a) 7 (b) 
     Absent 45 (c) 16 (d) 
Weakness   
     Present 84 (a) 23 (b) 
     Absent 0 (c) 0 (d) 
Data are n   
Table 2. Comparison of signs with the 
total score as standard 
Signs 
Neuropathy based 
on total score 
Present Absent 
Appearance of feet   
     Abnormal *84 (a) 20 (b) 
     Normal 0 (c) 3 (d) 
Ankle reflexes   
     Absent 64 (a) 15 (b) 
     Present 20 (c) 8 (d) 
Ulceration   
     Present 9 (a) 0 (b) 
     Absent 75 (c) 23 (d) 
Vibration Perception   
     Absent 52 (a) 7 (b) 
     Present 32 (c) 16 (d) 
Monofilament    
     Absent 14 (a) 3 (b) 
     Present 70 (c) 20 (d) 
* Data are n 
 
Table 3. Baseline characteristics of the 
study participants 
Variables  
Age 57.6 (± 10.2) 
Duration of DM 10.2 (± 7.3) 
HbA1c 8.8 (± 1.8) 
Gender   
     Female 72 (67.3%) 
     Male 35 (32.7%) 
BMI  
     ≤25 kg/m2 27 (25.2%) 
     >25 kg/m2 80 (74.8%) 
Diabetes treatment  
     Diet 3 (2.8%) 
     Oral agent ± diet 70 (65.4%) 
     Insulin ± Oral agent ± diet 34 (31.8%) 
Smoking  
     Yes 6 (5.6%) 
     No 94 (87.9%) 
     Former 7 (6.5%) 
Mean ± SD are shown for continuous variables and 
% is shown for categorical variables 
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weakness (78%), numbness (71%) and prickling feeling 
(63.5%) were the most accurate tests in the past history 
while, in the physical assessment appearance of feet 
(81.3%), ankle reflexes (67.2%), and vibration perception 
(62%) were the most accurate items (Tables 4 and 5).  
Data analysis also indicated a diagnostic accuracy of 
62.5% for absence of ankle reflexes in those less than 65 
yr. old compared to 81.4% in participants who were older.  
 
 
Discussion 
 
The current study rigorously examined the sensitivity, 
specificity and diagnostic accuracy of various items of 
MNSI to determine the most accurate test(s) to screen 
distal symmetric polyneuropathy (DPN) in an outpatient 
clinical setting. The results showed that muscle cramp, 
weakness, numbness and prickling are the most accurate 
diagnostic tests in patient history, and appearance of feet, 
ankle reflexes, and vibration perception are the most 
accurate tests in physical assessment. 
      Diabetes may be accompanied by cramping of 
muscles in the legs and arms. The disturbance of  
 
 
glycogenolysis, as a result, of diabetes mellitus is one 
possibility which could justify the mechanism of muscle 
cramps. Depending on the cause, cramping may occur in 
one muscle or a group of muscles, and it may be 
accompanied by sharp pain (14). Precise mechanisms of 
positive neuropathic symptoms such as pain, muscle 
cramps and their significance in diagnosis of DPN have 
not yet been clarified (15). 
In the present study, muscle cramp was the most 
sensitive and accurate test in the patient history; however, 
it had low specificity. This might be due to the presence 
of some other conditions such as dehydration, fatigue, 
Table 4. Test Performance Characteristics of the Symptoms compared with the total score as standard 
 
 
Sensitivity 
(CI) 
Specificity 
(CI) 
PPV 
(CI) 
NPV 
(CI) 
LR 
(CI) 
LR– 
(CI) Accuracy 
 
   
 
 
 
 
Numbness 72.6% (62.3 - 81) 
65.2% 
(44.9 - 81.2) 
88.4% 
(78.8 – 94) 
39.5% 
(25.6 - 55.3) 
2.088 
(1.175-3.71) 
0.42 
(0.265- 0.66) 71% 
Prickling 67.9% (57.3 - 76.9) 
47.8% 
(29.2-67) 
82.6% 
(72-89.8) 
47.8% 
(29.2-67) 
1.583 
(1.055-
2.376) 
0.364 
(0.186-
0.709) 
63.5% 
Burning pain 53.6% (43 – 63.8) 
73.9% 
(53.5 - 87.5) 
88.2% 
(76.6 -94.5) 
30.4% 
(19.9- 43.3) 
2.054 
(1.003-4.20) 
0.628 
(0.45-0877) 58% 
Sensitive to 
touch 
23.8% 
(16-33.9) 
82.6% 
(62.9-93) 
83.3% 
(64.1-93.3) 
22.9% 
(15.2-33) 
1.369 
(0.52-3.60) 
0.922 
(0.738-1.15) 36.4% 
Muscle Cramp 99.4% (94.6-99.9) 
2.1% 
(0.2-17.5) 
78.5% 
(69.8-85.2) 
50% 
(5.5-94.5) 
1.016 
(0.955-1.08) 
0.278 
(0.006-13.6) 78% 
Hurt by 
touching with 
bed covers 
27.4% 
(19-37.7) 
73.9% 
(53.5-87.5) 
79.3% 
(61.6-90.2) 
21.8% 
(14.1-32.2) 
1.05 
(0.485-2.27) 
0.982 
(0.746-1.29) 37.3% 
Hurt legs by 
walking 
20.2% 
(13-30) 
82.6% 
(62.9-93) 
81% 
(60-92.3) 
22.1% 
(14.6-31.9) 
1.164 
(0.43-3.12) 
0.966 
(0.77-1.20) 33.6% 
Worse at 
night 
46.4% 
(36.2-57) 
69.6% 
(49.1-84.4) 
84.8% 
(71.8-92.4) 
26.2% 
(16.8-38.4) 
1.526 
(0.79-2.94) 
0.77 
(0.55-1.07) 51.4% 
weakness 99.4% (94.6-99.9) 
2.1% 
(0.2-17.5) 
78.5% 
(69.8-85.2) 
50% 
(5.5-94.5) 
1.016 
(0.955-1.08) 
0.278 
(0.006-13.6) 78% 
Dry Skin 42.9% (32.8-53.5) 
52.2% 
(33-70.8) 
76.6% 
(62.8-86.4) 
20% 
(11.8-31.8) 
0.896 
(0.54-1.46) 
1.095 
(0.71-1.689) 45% 
History of 
amputation 
0.6% 
(0.1-5.4) 
97.9% 
(82.5-99.8) 
50% 
(5.5-94.5) 
21.5% 
(14.8-30.2) 
0.278 
(0.006-
13.64) 
1.016 
(0.955-1.08) 21% 
Open sore 14.3% (8.4-23.3) 
95.7% 
(79-99.2) 
92.3% 
(66.7-98.6) 
23.4% 
(16-32.9) 
3.286 
(0.45-23.96) 
0.896 
(0.79-1.014) 31.8% 
CI: Confidence Interval 
PPV: Positive Predictive Value 
LR-: Likelihood Ratio for negative test results 
NPV: Negative Predictive Value 
LR+: Likelihood Ratio for positive test results 
L. Najafi, et al. 
Acta Medica Iranica, Vol. 52, No. 7 (2014)    523 
poor peripheral circulation, and nerve compression.  
 
 
Severe and advanced diabetic polyneuropathy leads to 
motor disturbances, distal weakness and atrophy of the 
muscles of the lower leg and foot (16). It might be 
associated with atrophy of muscle, probably because of 
inadequate reinnervation (17,18). Present results show 
that the weakness had sensitivity of 99.4% with 
diagnostic accuracy of 78%. However, the specificity of 
the test was poor.  
Other studies (19-21) also reported an association 
between neuropathy and muscle weakness; present 
observation supports this finding. In another study 
conducted by Andreassen et al., on 30 diabetic and 30 
matched control subjects, seven patients reported 
muscular weakness.  
Clinical signs of muscular weakness were found in 10 
of the diabetic subjects, of whom eight had symptomatic 
neuropathy (22). No follow-up study in diabetic 
neuropathy has been conducted concerning muscle 
weakness, even though motor function evaluated as part 
of the clinical assessment, is included in some studies 
(5,23). 
Numbness is one of the most sensitive items in the 
patient history. Franse et al., in a study investigated 
whether sensory symptoms of neuropathy could be 
used as a diagnostic or screening tool for detection of 
diabetic polyneuropathy in general practice. Franse et 
al., reported that prediction of diabetic polyneuropathy 
with these symptoms is not convincing. The sensitivity 
and specificity of numbness were reported to be 28% 
and 93%, in patients less than 68 years old. Similar 
results were reported for older patients (24). It was 
concluded that neuropathic sensory symptoms are not 
useful as a diagnostic or screening tool in the 
evaluation of diabetic neuropathy in daily practice. The 
authors suggested an annual foot examination by a 
general practitioner. In contrast, current study revealed 
higher sensitivity in < 65 years’ old participants and ≥ 
65 years, but lower specificity in both groups Table 6 
shows test performance characteristics of numbness by 
the age category. 
This difference might be justified by different races 
and different geographic area being examined in these 
studies (24).  
 
Table 6. Test Performance 
Characteristics of Numbness by  
the age category 
 Numbness <65 yr 
Numbness 
≥65 yr 
Sensitivity (CI) 67.8% (55-78.3) 
95.5% 
(78.2-99.2) 
Specificity (CI) 66.7% (45.4-82.8) 
20% 
(3.6-62.4) 
PPV 
(CI) 
85.1% 
(72.3-92.6) 
84% 
(65.3-93.6) 
NPV 
(CI) 
42.4% 
(27.2-59.2) 
50% 
(9.5-90.5) 
LR+ 
(CI) 
2.034 
(1.08-3.81) 
1.19 
(76.3-1.86) 
LR–
(CI) 
0.48 
(0.30-78) 
0.22 
(0.01-3.04) 
Accuracy 67.5% 81.4% 
CI: Confidence Interval 
PPV: Positive Predictive Value 
NPV: Negative Predictive Value 
LR+: Likelihood Ratio for positive test results 
LR-: Likelihood Ratio for negative test results 
Table 5. Test Performance Characteristics of the Signs compared with the total score as standard 
 
 
Sensitivity 
(CI) 
Specificity 
(CI) 
PPV 
(CI) 
NPV 
(CI) 
LR+ 
(CI) 
LR– 
(CI) Accuracy 
 
     
 
 
 
 
Appearance of 
feet 
99.9%  
(95.6 - 100) 
13.1% 
 (4.6 – 32.2) 
80.8%  
(72.1 – 87.2) 
99.7%  
(43.7 - 100) 
1.15  
(0.98 - 1.35) 
0.01 
(0.00- ~) 81.3% 
Ankle reflexes 76.2% (66.1-84) 
34.8%  
(18.8-55.1) 
81%  
(71 – 88.1) 
28.6%  
(15.3-47.1) 
1.16 
(0.84-1.61) 
0.68 
(0.34 -1.34) 67.2% 
Ulceration 10.7%  (5.7 - 19.1) 
100%  
(85.6 - 100) 
99.9%  
(70-100) 
23.5%  
(16.2 – 33) 
246.8 
 (0.00- ~) 
0.89 
 (0.82 -0.96) 30% 
Vibration 
perception 
62%  
(51.2-71.6) 
70%  
(49.1-84.4) 
88.1%  
(77.5-94.1) 
33.3% 
 (21.7-47.5) 
2.034 
(1.07-3.85) 
0.54  
(0.37-0.80) 63.5% 
Monofilament 16.7%  (10.2-26.1)  
87%  
(67.9-95.5) 
82.4% 
 (59-93.8) 
22.2%  
(14.9-31.8) 
1.278 
(0.40-4.07) 
0.958  
(0.8-1.15) 31.7% 
CI: Confidence Interval 
PPV: Positive Predictive Value 
NPV: Negative Predictive Value 
LR+: Likelihood Ratio for positive test results 
LR-: Likelihood Ratio for negative test results 
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The current study showed that prickling feeling had 
sensitivity of 67.9% with specificity of 47.8%. The 
positive predictive value of the test was 82.6% and its 
negative predictive value was 47.8%. It was one of the 
most accurate tests in history to detect DPN. In another 
study conducted in Brazil, a questionnaire consisting of 
fifteen questions was applied to evaluate diabetic 
neuropathy. The most prevalent symptom reported by the 
patients was prickling (67%) (25) which is a prototypical 
symptom of diabetic neuropathy (26). Thus, it may be an 
accurate test for diagnosis of DPN in a busy clinical 
setting.  
Ankle reflexes were also used for assessing peripheral 
neuropathy. In present study, absent ankle reflex was 
highly sensitive (76.2%) with accuracy of 67.2% and 
specificity of 34.8%. Another study reported almost the 
same sensitivity but higher specificity (89%) for absent 
ankle reflexes (27) . Meanwhile, Shehab et al(28) showed 
that ankle reflex is highly sensitive (91.5%) and specific 
(67.4%); taking nerve conduction studies (NCS) as the 
gold standard for comparison. Thus, ankle reflexes can be 
considered as a reliable option for DPN assessment. 
Diagnosis of DPN based on absent ankle reflexes is a 
matter of debate because of the fact that absent ankle 
reflexes could be seen in the normal population (29). This 
possibly happens because of coexisting obesity, 
peripheral edema, concurrent micronutrient deficiency 
and taking various drugs including beta blockers. In 
addition, there is an age dependent increase in the 
prevalence of absent ankle reflexes. In a study of 1074 
normal adults, the proportion of subjects with absent 
ankle reflexes increased rapidly from 5 per cent in the age 
group of 40-50 to 80 per cent in those over 90 years old 
(30) . In contrast to this report, the results of this study 
indicated that ageing could not significantly affect the 
performance characteristics of this test in evaluation of 
DPN. Table 7 presents test performance characteristics of 
ankle reflex by the age category. 
 
Table 7. Test Performance Characteristics of Loss of 
Ankle Reflex by the age category 
 
 
Loss of ankle reflex 
< 65 yr 
Loss of ankle reflex 
≥65 yr 
Sensitivity (CI) 74.6%(62.2-84) 80%(61-91) 
Specificity (CI) 28.6%(13.8-50) 99.9%(34.-100) 
PPV (CI) 74.6%(62.2-84) 100%(83.8-100) 
NPV (CI) 28.6%(13.8-50) 28.6%(8.3-64) 
LR+ (CI) 1.044(0.76-1.42) 161.6(0.0- ~) 
LR– (CI) 0.89(39.8-1.99) 0.201(0.09-0.44) 
Accuracy 62.5% 81.4% 
CI: Confidence Interval 
PPV: Positive Predictive Value 
NPV: Negative Predictive Value 
LR+: Likelihood Ratio for positive test results 
LR-: Likelihood Ratio for negative test results
 
Appearance of feet was the most sensitive item 
(99.9%) to detect DPN in the current study with 
diagnostic accuracy of 81.3%. Peripheral neuropathy 
interferes with normal protective mechanisms and puts 
patients at risk of major or repeated minor trauma to the 
foot. Disordered proprioception causes misjudgment of 
foot position, resulting in increased risk of fall (31) and 
abnormal weight bearing leading to callus formation or 
ulceration (32). Motor and sensory neuropathy result in 
abnormal foot muscle mechanics and turn into structural 
changes in the foot (hammer toe, claw toe deformity, 
prominent metatarsal heads, and Charcot joint) (32). 
Thus, the presence of changes of the leg and foot, 
abnormal hair loss, infection, fissures, calluses (including 
the heels and web spaces), and deformities should be 
noted while assessing diabetic neuropathy (33).  
 
The 128 Hz tuning fork provides a simple, applicable 
and inexpensive test of vibration. In some studies, the 
sensitivity and specificity of vibration testing for 
peripheral neuropathy are 53 and 99 per cent, respectively 
(34, 35). In the study conducted by Jayaprakash et al. a 
better sensitivity (62.5%) and a lower specificity (95%) 
are reported (36). Current study showed a high sensitivity 
(62%) and specificity (70%), making this test as one of 
the most useful modalities to detect DPN. 
As vibration perception (VP) testing is not 
significantly affected by the presence of foot callus or by 
limb temperature (37), it can provide clinically important 
information about large nerve fiber dysfunction in 
diabetes. The neurological deficits associated with large 
fiber neuropathy account for 80% of the morbidity 
associated with DPN (38). The majority of long-term 
complications of diabetes such as ulceration and 
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amputation are preceded by abnormal VP values (39). 
However, VP testing is not sufficiently specific to large 
fiber or even to peripheral nerve dysfunction, and the 
results are influenced by subject attentiveness, motivation, 
and fatigue (37,40-42) . In other words, its reproducibility 
may vary in non-diabetic and diabetic patients (37,42) . 
VP can be an optimal option for DPN assessment in a 
busy clinical setting, considering the pros and cons of VP 
and the presence of standard algorithms,  
The most commonly used modality for evaluating 
neuropathy in daily clinics is the Semmes-Weinstein 
monofilament examination (43). Various case-control 
studies reported variable sensitivity and specificity for 
monofilament sensation up to 95 and 82 per cent, 
respectively (44,45). In the study conducted by 
Jayaprakash et al (36) in India, results showed 
sensitivity of 63 per cent and specificity of 93 per cent 
for monofilament sensation for the diagnosis of 
neuropathy. Other studies, indicated that abnormal 
results of Semmes-Weinstein monofilament 
examination, increase the likelihood of peripheral 
neuropathy (35,46,47). Despite differences in technique 
and threshold values, an abnormal test has a likelihood 
ratio in favor of the neuropathy (48). 
In contrary to the above studies, monofilament 
examination had poor sensitivity in this study, though it 
was highly specific. Regarding the results of this study 
and the systematic review done by Dros et al, despite the 
common use of monofilament examination, the accuracy 
of the test for evaluating neuropathy in feet without 
frank ulcers is questionable. It should be emphasized 
that the results of monofilament testing depends on 
“Optimal test application” and “defining a threshold” 
(49). In a study by Miranda‐Palma et al. the number of 
testing sites and the proportion needed to be insensate 
for the optimal assessment of foot ulcer risk was 
assessed. They showed that the sensitivity of 
monofilament examination was less than NDS and 
biothesiometer (50).  
Feng et al. in a systematic review concluded that there 
is great variation in the current literature regarding the 
diagnostic value of monofilament examination because of 
different methodologies (51). 
Taking the above evidence into consideration, 
monofilament examination should not be used as the 
optimum modality to diagnose peripheral neuropathy as 
its accuracy is low. 
Although present study assessment showed muscle 
cramp, weakness, numbness, prickling, and appearance 
of feet, ankle reflexes, and vibration perception as the 
most accurate tests in a busy outpatient clinical setting, 
further studies using nerve conduction velocity tests are 
needed to confirm these results. In addition, using 
monofilament examination as the optimal test to detect 
patients at risk of DPN is controversial and there is still 
a need to formulate a standard protocol for the test 
application.  
The high prevalence of DPN in current study might 
be attributed to the fact that this study was conducted in 
a tertiary referral center; therefore, the results could not 
be generalized to all diabetic patients. 
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